Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Aug 8, 2019 at 1:05 PM EDT

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas,…

Chris Lange | Aug 5, 2019 at 10:45 AM EDT

Is GlycoMimetics’ Sickle Cell Study Done For?

GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction…

Jon C. Ogg | Jul 30, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Cisco Systems, Duke Energy, Goodyear, Illumina, Kinder Morgan, Micron…

Chris Lange | Jul 29, 2019 at 12:05 PM EDT

What to Watch When Merck and Pfizer Report Early on Tuesday

Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of…

Chris Lange | Jul 29, 2019 at 9:25 AM EDT

What This Mylan-Pfizer Pharma Juggernaut Will Look Like

Mylan released its second-quarter financial results before the markets opened on Monday. The pharma giant also announced a major update…

Chris Lange | Jul 28, 2019 at 10:20 AM EDT

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including…

Douglas A. McIntyre | Jul 27, 2019 at 7:28 AM EDT

This Stock Is Killing the Dow

The Dow Jones industrial average in an all-time high territory, and a lot of experts believe it has room to…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Jul 25, 2019 at 6:40 AM EDT

Intel Overtakes Pfizer as Most Shorted Dow Stock

As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Jul 11, 2019 at 6:35 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Lee Jackson | Jul 10, 2019 at 6:35 AM EDT

Merrill Lynch Has 5 Stocks to Buy That Could Beat Q2 Earnings Estimates

Here are five solid defensive picks for investors in what is a very expensive market, and they are also under-owned…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Chris Lange | Jul 8, 2019 at 3:49 PM EDT

Will Sangamo and Pfizer’s Hemophilia Gene Therapy Keep Building Momentum?

Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated…

Chris Lange | Jul 1, 2019 at 10:00 AM EDT

How Pfizer Is Looking to Expand Its Eczema Treatment

Pfizer shares were up slightly on Monday after the firm announced topline results from its most recent late-stage study in…

1 … 25 26 27 28 29 … 98

Pfizer : PFE

All Pfizer Articles

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Is GlycoMimetics’ Sickle Cell Study Done For?

Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More

What to Watch When Merck and Pfizer Report Early on Tuesday

What This Mylan-Pfizer Pharma Juggernaut Will Look Like

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

This Stock Is Killing the Dow

Short Sellers Up the Ante in Big Pharma

Intel Overtakes Pfizer as Most Shorted Dow Stock

Big Pharma Sees Rising Tide in Short Interest

The 5 Most Shorted Dow Stocks

Merrill Lynch Has 5 Stocks to Buy That Could Beat Q2 Earnings Estimates

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Will Sangamo and Pfizer’s Hemophilia Gene Therapy Keep Building Momentum?

How Pfizer Is Looking to Expand Its Eczema Treatment

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Ray Dalio Warns U.S. Faces ‘Particularly Risky Period’ Between 2026 and 2028 Elections

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Pfizer : PFE

All Pfizer Articles

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Is GlycoMimetics’ Sickle Cell Study Done For?

Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More

What to Watch When Merck and Pfizer Report Early on Tuesday

What This Mylan-Pfizer Pharma Juggernaut Will Look Like

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

This Stock Is Killing the Dow

Short Sellers Up the Ante in Big Pharma

Intel Overtakes Pfizer as Most Shorted Dow Stock

Big Pharma Sees Rising Tide in Short Interest

The 5 Most Shorted Dow Stocks

Merrill Lynch Has 5 Stocks to Buy That Could Beat Q2 Earnings Estimates

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Will Sangamo and Pfizer’s Hemophilia Gene Therapy Keep Building Momentum?

How Pfizer Is Looking to Expand Its Eczema Treatment

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Ray Dalio Warns U.S. Faces ‘Particularly Risky Period’ Between 2026 and 2028 Elections

Featured Reads

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures